Rankings
▼
Calendar
CAMP Q4 2020 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena
CAMP
CAMP4 Therapeutics Corporation
$126M
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$88M
-8.9% YoY
Gross Profit
$35M
39.8% margin
Operating Income
-$20M
-22.7% margin
Net Income
-$24M
-26.9% margin
EPS (Diluted)
$-0.68
QoQ Revenue Growth
+5.4%
Cash Flow
Operating Cash Flow
$10M
Free Cash Flow
$7M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$442M
Total Liabilities
$343M
Stockholders' Equity
$99M
Cash & Equivalents
$92M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$88M
$97M
-8.9%
Gross Profit
$35M
$37M
-5.1%
Operating Income
-$20M
-$4M
-400.7%
Net Income
-$24M
-$7M
-219.4%
Revenue Segments
Product
$58M
66%
Application Subscriptions And Other Services
$30M
34%
Geographic Segments
UNITED STATES
$61M
69%
E M E A
$14M
16%
South America
$7M
8%
Asia Pacific
$4M
5%
All Other
$2M
2%
← FY 2020
All Quarters
Q1 2021 →